Semin intervent Radiol 2003; 20(4): 307-322
DOI: 10.1055/s-2004-828942
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Lung Radiofrequency Ablation

Sapna K. Jain, Caroline J. Simon, Damian E. Dupuy
  • Rhode Island Hospital, and Brown Medical School, Providence, Rhode Island
Further Information

Publication History

Publication Date:
20 July 2004 (online)

Preview

ABSTRACT

Lung cancer is the leading cause of death among men and women in the United States. Utilizing the best current therapies results in an overall 5-year relative survival rate of 15% for all stages, necessitating the use of alternative therapies. Radiofrequency ablation (RFA) is an expanding modality for the local control of non-small cell lung cancer (NSCLC). The technique and application of RFA in pulmonary neoplasms will be discussed in addition to early clinical experience.

REFERENCES